Dichlorphenamide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dichlorphenamide. Educational only — not medical advice.
Labeled uses
Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
Source: FDA labeling via NIH DailyMed (set 35b9c81a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.